Presenting the relevance and importance of HPV mRNA E6/E7 biomarkers in the prevention of cervical cancer
69 Congreso Mexicano de Obstetricia y Ginecologia
Combining Mia by XytoTest cervicovaginal sampling with Hr-HPV DNA analysis via PCR Real-Time and biomarkers mRNA E6/E7 for seven high risk HPV genotypes..
Cervical Cancer in the developing world
West J Med.
A lack of effective screening programs aimed at detecting and treating precancerous conditions is a key reason for the much higher cervical cancer incidence in developing countries. It has been estimated that only about 5% of women in developing countries have been screened for cervical dysplasia in the past 5 years, compared with 40% to 50% of women in developed countries.
High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening
International Journal of Cancer
This review elaborates on the accuracy and feasibility of human papillomavirus (HPV) self-sampling, i.e., offering self-sampling of (cervico-)vaginal cell material by women themselves in nonclinical settings for high-risk HPV (hrHPV) detection in the laboratory, for cervical screening.